AURANEN , M.

Last name: AURANEN

First name: M.

2018 (v1)

Publication

Metadata-only

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N Bril, Vera van Geloven, Nan

Background Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) need long-term intravenous immunoglobulin. Subcutaneous immunoglobulin (SCIg) is an alternative option for immunoglobulin delivery, but has not previously been investigated in a large trial of CIDP. The PATH study compared relapse rates...

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

Mielke, Orell Bril, Vera Cornblath, David R.

In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to assess the need for ongoing therapy. However, little is known about the effectiveness of restabilization with IVIG in patients who worsen after IVIG withdrawal. In the Polyneuropathy And...

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP PATH extension study

van Schaik, Ivo N. Mielke, Orell Bril, Vera

No description

Uploaded on: February 23, 2024

AURANEN , M.

Recent uploads